Pacira Pharmaceuticals (PCRX) PT Lifted to $133 at Wedbush
Tweet Send to a Friend
Wedbush analyst Liana Moussatos reiterated an Outperform rating and boosted her price target on Pacira Pharmaceuticals (NASDAQ: PCRX) to $133.00 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE